Tuesday, Quest Diagnostics Inc (NYSE:DGX) posted first-quarter adjusted EPS of $2.04, beating the consensus of $1.86. Sales came in at $2.37 billion, up 1.5% Y/Y, higher than the Wall Street estimate of $2.29 billion. “In the first quarter, we delivered nearly 6% base business revenue growth, continuing the strong momentum of recent quarters. We also grew total revenues for the first time since the height of the pandemic nearly three years ago,” said Jim Davis, Chairman, CEO and President. “Our strong commercial focus on physicians and hospitals combined with our broad health plan access enabled us to take ...